The 13C-NMR spectra of I-N-[(S)-4-amino-2-hydroxybutyl]kanamycin A (butikacin) (Fig. 1, 1b) and some of its related compounds have been recorded and are tabulated, assigned and discussed. The chemical shifts of many of the carbon nuclei are shown to be reasonably invariant amongst this series of compounds.
13
C-NMR spectroscopy has become a powerful technique for the structural elucidation and characterisation of aminocyclitol-aminoglycoside entibioticsl1,7). In this present paper, the fully assigned 13C-NMR spectra are described for the aminoglycoside antibiotic 1-N-[(S)-4-amino-2-hydroxybutyl]karamycin A (butikacin) and its related compounds including the R-epimer (1c), and the 3-and 3"-N-substituted positional isomers (Fig. 1, 1d and 1e). The synthesis and antibacterial activities of butikacin and some of its 1-N-[(S)-ol-amino-2-hydroxyalkyl] analogues have been reported8).
The large number of publications on the application of 13C-NMR spectroscopy for the structural elucidation of aminoglycosides in recent years has afforded a wealth of 13C-NMR spectral data on common arninoglycosides and their constituent moieties for workers in this field. Much of these data have been utilised in this present work. In the 13C-NMR spectra of a structurally similar series of arninoglycosides obtained under identical conditions, the chemical shifts of nuclei in a particular environment are relatively invariant, provided there is no molecular modification within three bonds of the carbon nucleus under examination. It is therefore possible to make unambiguous assignments by comparison with the chemical shifts of comparable 13C nuclei in structurally similar model compounds whose spectra have been assigned.
Well-resolved 13C-NMR spectra were obtained for all the compounds examined and spectral assignment was facilitated by 13C chemical shift changes produced by changes of the pD of their solutions in deuterium oxide; the "fl-shift" effect. Deuteronation of amino groups causes large upfield shifts of the resonance signals of 13C nuclei which are /3-to the amino groups3,5).
These /3-carbons can be readily assigned and this coupled with substituent effects and glycosidation shifts, which are documented9), provides unambiguous assignment of the 13C-NMR spectra of aminoglycosides. Further confirmation of spectral assignments was achieved from single frequency off-resonance decoupling (SFORD) experiments.
Finally, the potential racemisation of the (S)-4-amino-2-hydroxybutyl moiety during the synthesis of butikacin has been monitored and ratios of the (S)-1b to (R)-1c epimers determined by quantitative 13C-NMR spectroscopy . These resonances were assigned to C-l' and C-1-respectively by comparison with the 13C-NMR spectra of kanamycin A (1a). The 4.0 ppm upfield shift of the C-1' resonance on deuteronation is typical for this anomeric carbon in the 13C-NMR spectra cf other similar aminoglycosides6). The shift is anomalous since C-1" is not /j'-to an amino group and arises due to steric interaction between the 6-amino-6-deoxy glucose and 2-deoxystreptamine rings10). The small downfield shift of 0.7 ppm by the C-1" carbon resonance is characteristic of this particular carbon nucleus6). The anomeric carbons C-1' and C-t" in compounds 1e, 1d and 1e were assigned using parallel arguments to those proposed for butikacin. The increased shielding of C-1' by 2.1 ppm in 1d at pD 3, compared to butikacin, is indicative of an increase in the steric shift due to the presence of the N-(S)-4-amino-2-hydroxybutyl moiety on the 3-amino group.
The aglycon carbon resonances in butikacin were readily identified since these appear in the by the N-alkylation of an amino group in the fl-position1). Similarly, the C-4 resonance of 1d at pD 11 is shielded by 2.4 ppm relative to the C-4 resonance of kanamycin A and pD 11 whereas the C-6
Fie.
1 R1 In resonance has essentially the same chemical shift in the spectra of both compounds.
In the spectrum of 1e at pD 11, the C-4 and C-6 resonances have similar chemical shifts to those observed in kanamycin A at pD 11. However, the C-2" and C-4" resonances are both shielded by 1.0 ppm compared to their equivalents in kanamycin A. The shielding of C-2" and C-4" in 1e is indicative of N-alkylation at their common /3-carbon, C-3". This reduced shielding may be caused by the equatorial hydroxyl groups at C-2" and C-4" whose combined negative inductive effect clearly counteracts some of the shielding provided by the N-(S)-4-amino-2-hydroxybutyl group at C-3". These observations provide evidence that 1b and 1c are N-alkylated at C-1 ; 1d is N-alkylated at C-3 and 1e
is N-alkylated at C-3". The magnitudes of the alkylation shifts at the N-alkylated carbons are fairly consistent at pD 3 and pD 11. These are downfield shifts which range from 4.4 -7.1 ppm. The magnitude and direction of these alkylation shifts are typical for N-alkylated aminoglycosides. In the spectrum of N-methyl-2-deoxystreptamine1), the C-1 carbon resonance moves downfield 7.6 ppm while C-3 is not shifted com-THE JOURNAL OF ANTIBIOTICS APR. 1979 pared to their respective positions in the spectra of 2-deoxystreptamine.
The C-2 methylene carbon in butikacin is identified by the high field resonance at 33.5 ppm at pD 11. This resonance, for which SFORD reveals a triplet, is observed at the same position as the C-2 methylene resonance of N-methyl-2-deoxystreptamine1) and the upfield shift of 6.8 ppm on deuteronation
indicates that the C-2 carbon is /3-to two amino groups. The resonance at 32.7 ppm (pD 3) is attributed to the C-3"' carbon of the N-(S)-4-amino-2-hydroxybutyl group by comparison to analogous carbons, designated S3, in the spectrum of butirosin A sulphate4) and C/ in the spectrum of amikacin7)
at the same pD. This resonance, for which SFORD shows an expected triplet, shifts upfield by 5.7 ppm on deuteronation and verifies that C-3"' in butikacin is /3-to an amino group. A resonarce at 38.4 ppm which shifts to 37.5 ppm on deuteronation is assigned to C-4"' by analogy with the spectrum of butirosin A4) and amikacin7). The assignments of C-6' and C-4"' were confirmed by SFORD experiments which revealed two triplets. In the spectrum of 1-N-methyl-2-deoxystreptamine1), the C-1 resonance moves downfield 7.6 ppm and the position of the C-3 resonance remains unchanged compared to their respective positions in the spectrum of 2-deoxystreptamine2). On this evidence the resonance at 57.9 ppm, which is 6.5 ppm downfield of the C-1 carbon resonance of kanamycin A, was assigned to the C-l carbon of butikacin and the resonance at 50.0 ppm was assigned to the C-3 carbon since this appeared at the same position as the C-3 carbon resonance of kanamycin A. The remaining resonance at 53.0 ppm was assigned to the C-1"' carbon for which SFORD showed a triplet. The two resonances at 74.4 and 73.5 ppm were assigned to the C-5' and C-5" carbons which are directly bonded to ring oxygen atoms. Since only the C-5' resonance undergoes a deuteronation shift, these carbons were readily distinguished. The remaining resonance at 69.9 ppm was assigned to C-2"'. This undergoes a 3.8 ppm upfield shift on deuteronation.
The 13C-NMR evidence presented so far has established the structure of butikacin. This indicates that the molecular structure consists of a 2-deoxystreptamine ring linked at the C-4 and C-6 positions THE .JOURNAL OF ANTIBIOTICS VOL.
XXXII NO. 4 to 6-amino-6-deoxy-x-D-glucose and 3-amino-3-deoxy-x-o-glucose respectively. An (S)-4-amino-2-hydroxybutyl group is attached to the C-1 amino group. Similar evidence has been presented and discussed to confirm the structures of compounds 1e to 1e inclusive.
Examination of the deuteronation shifts of the carbons in the N-(S)-4-amino-2-hydroxybutyl side chain of compounds 1d and 1c has revealed some interesting results.
In compound 1d, C-2"' is shielded by ca. 2.0 ppm compared to the C-2"' carbons in compounds 1b and 1e at pD 11.
This results in a deuteronation shift of only 1.8 ppm upfield in the case of 1d as opposed to 3.8 ppm for butikacin and 4.9 ppm for 1e. These latter values are those normally expected for carbons which are /J-to amino groups. Similarly C-1"' is shielded by 1.9 ppm compared to C-1"' in butikacin. It is suggested that in 1d, the protons bonded to C-1"' and C-2"' experience intramolecular steric perturbations which shield the C-1 "' and C-2"' nuclei. This occurs as a direct consequence of the close proximity of the 6-amino-6-deoxy-y-n-glucose ring. KOCH et al.5 ) have showed that a preferred rotamer conformation exists in many aminoglycosides in which the 6-amino-6-deoxy---D-glucose ring is inclined towards the C-3 carbon of the 2-deoxystreptamine ring.
This not only results in
shielding of the C-3 carbon nucleus but also shields the carbon nuclei present in substituent groups attached to the C-3 amino group.
Examination of the chemical shift of C-1"' in 1e at pD 11 shows that this carbon is deshielded by 1.7 ppm compared to C-1"' in butikacin.
The amino group at C-3"' is unique in that it is /J-to two carbons bearing equatorial hydroxyl groups whose combined negative inductive effect may account for this difference.
Since 1b and 1c are epimers it was postulated that directly comparable carbon nuclei (e.°. C-1, C-1'" and C-2"') within the vicinity of the chiral centre C-2"' would have different chemical shifts in the two epimers. This phenomenon was observed; the largest difference in chemical shift occurring
for carbon nuclei C-1 (ca. 1 ppm) at pD 3 and pD 11. Measurements of the intensities of the C-2-carbon lines in the spectra, using the technique of quantitative 13C-NMR spectroscopy11), indicated levels of 1c present in bulk lots of butikacin.
The method postulates that (a) the spin-lattice relaxation times (TI) of comparable carbons in both epimers are equal and (b) that the amount of Nuclear OVERHAUSER Effect signal enhancement from bonded protons on the carbon nuclei of interest is identical for comparable carbon nuclei in each epimer. Results in our laboratory have confirmed the validity of these two fundamental assumptions.
Four samples of butikacin, spiked with known levels of 1e were prepared and their 13C-NMR spectra recorded under identical conditions. The intensities of the C-2-peaks arising from lb and 1c were acquired from the data outputs associated with the FOURIER-transformed spectra. Table 2 .
The results in Table 2 were used to assess the value of quantitative C-13NMR spectroscopy as a technique for determining the levels of 1c in bulk lots of butikacin. For this purpose, the method was considered satisfactory for determining levels of 1c in butikacin down to 4% relative. Although used as a quality control and in-process control monitoring technique initially, it was later considered unsuitable for routine use and was superseded by an h.p.l.c. method.
Experimental 1 3C -NMR Spectra
Proton noise decoupled 13C-NMR spectra were recorded at a frequency of 25.2 MHz on a
Varian XL-100-15 spectrometer operating in the FOURIER Transform mode.
The instrument used deuterium oxide, the solvent for all this work, as a source of deuterium for the lock signal. A Varian 620L computer was used to accumulate 10-30,000 transients of 5,000 Hz width and the proton noise decoupler used a 1,500 Hz bandwidth to ensure complete decoupling. Square wave modulation of the proton decoupling frequencies using a Level R.C. Oscillator assured consistency in decouplig;
power over the total bandwidth. SFORD experiments were accomplished by off-setting the proton noise decoupler by 400 Hz.
In general, 300-400 mg of the sample under examination was dissolved in 1.5 ml of deuterium oxide and the pD of the solution was adjusted with 0.1 M deuteriochloric acid or sodium deuteroxide as appropriate.
Chemical shifts were measured relative to the 13C signal of let ramethylsi lane (11=0.00 rpm) as an external standard enclosed in a 1-mm glass capillary.
